Nuclear Medicine Market Share
ID: MRFR/HC/5211-CR
200 Pages
July 2025
Nuclear Medicine Market Research Report By Application (Diagnostic Imaging, Therapeutic Applications, Radiopharmaceutical Production, Research Applications), By Radioisotope Type (Technetium-99m, Iodine-131, Fluorine-18, Yttrium-90), By End User (Hospitals, Diagnostic Imaging Centers, Academic Research Institutions, Pharmaceutical Companies), By Procedure (Positron Emission Tomography, Single-P...
Market Summary
As per Market Research Future analysis, the Nuclear Medicine Market was valued at 10.63 USD Billion in 2024 and is projected to grow to 34.69 USD Billion by 2035, reflecting a CAGR of 11.35% from 2025 to 2035. The market is driven by the increasing prevalence of chronic diseases, advancements in diagnostic imaging technologies, and a rising geriatric population. Key regions contributing to growth include North America, Europe, and the Asia-Pacific, with significant investments in healthcare infrastructure and nuclear medicine applications.
Key Market Trends & Highlights
The Nuclear Medicine Market is witnessing transformative trends driven by technological advancements and demographic shifts.
- Market Size in 2024: 10.63 USD Billion; expected to reach 34.69 USD Billion by 2035. Diagnostic Imaging segment valued at 2.1 USD Billion in 2024; projected to grow to 3.3 USD Billion by 2035. Technetium-99m remains a leading radioisotope, crucial for diagnostic imaging. North America holds the largest market share in 2024, valued at 2.73 USD Billion.
Market Size & Forecast
| 2024 Market Size | USD 10.63 Billion |
| 2035 Market Size | USD 34.69 Billion |
| CAGR (2025-2035) | 11.35% |
| Largest Regional Market Share in 2024 | North America. |
Major Players
<p>MediRadiant, Bracco Imaging, Nordion, TheraBiologics, United Imaging Healthcare, Philips, Canon Medical Systems, SelenoMed, Radiopharm Theranostics, AquaBounty Technologies, Lantheus Medical Imaging, Bayer, Elekta, Siemens, General Electric.</p>
Market Trends
The Nuclear Medicine Market is experiencing significant growth driven by several key market drivers, particularly the rising incidence of cancer and cardiovascular diseases, which increase the demand for advanced diagnostic imaging and targeted therapies. The aging population globally is another critical factor, as older individuals are more susceptible to conditions warranting nuclear medicine interventions.
Advances in radiopharmaceutical technology are enhancing the accuracy and effectiveness of diagnostics and therapeutics, offering better patient outcomes and boosting market growth. In terms of opportunities, there is a growing potential in the development of personalized medicine, where nuclear medicine can play a vital role in tailoring treatments based on the individual characteristics of patients.Furthermore, investments in research and development are generating opportunities for the development of innovative products, such as novel radiotracers and therapies that more effectively target specific diseases.
The significance of nuclear medicine in enhancing healthcare outcomes is being acknowledged by governments and health organizations worldwide, resulting in a rise in funding and support for initiatives in this field.
PET-CT technology and theranostics, which integrates therapy and diagnostics in a single approach, are recent trends in the Nuclear Medicine Market. This trend signifies a transition to more comprehensive treatment strategies, which improves the capacity to effectively monitor and treat diseases. Additionally, the prevalence of collaborations between technology companies and medical institutions is increasing, with the objective of optimizing production and distribution processes. This has the potential to resolve supply chain challenges and enhance access to nuclear medicine services.
In general, the market is on the brink of significant growth, as its future trajectory is influenced by significant advancements in technology, healthcare delivery, and patient-centric approaches.
<p>The Global Nuclear Medicine Market is poised for growth, driven by advancements in radiopharmaceuticals and increasing applications in diagnostics and therapeutics, which collectively enhance patient care and treatment outcomes.</p>
U.S. Department of Energy
Nuclear Medicine Market Market Drivers
Market Growth Projections
Increasing Demand for Diagnostic Imaging
The Global Nuclear Medicine Market Industry experiences a notable surge in demand for diagnostic imaging techniques, particularly in oncology, cardiology, and neurology. As healthcare providers increasingly adopt advanced imaging modalities, the market is projected to reach 6.21 USD Billion in 2024. This growth is driven by the rising prevalence of chronic diseases and the need for early diagnosis. Nuclear medicine offers unique advantages, such as the ability to visualize physiological processes in real-time, which enhances treatment planning and patient outcomes. Consequently, the integration of nuclear imaging into routine clinical practice is likely to bolster the industry's expansion.
Regulatory Support and Reimbursement Policies
Regulatory support and favorable reimbursement policies are pivotal in shaping the Global Nuclear Medicine Market Industry. Governments and health authorities are increasingly recognizing the importance of nuclear medicine in improving patient outcomes, leading to the establishment of supportive regulatory frameworks. Additionally, reimbursement policies that cover nuclear medicine procedures encourage healthcare providers to adopt these technologies. This supportive environment is likely to stimulate market growth, as it enhances the financial viability of nuclear medicine services. Consequently, the industry is poised for expansion as more healthcare facilities integrate nuclear medicine into their offerings.
Rising Awareness of Nuclear Medicine Benefits
Rising awareness of the benefits of nuclear medicine among healthcare professionals and patients plays a crucial role in the Global Nuclear Medicine Market Industry. Educational campaigns and professional training programs are increasingly highlighting the advantages of nuclear imaging and therapy, such as their non-invasive nature and ability to provide functional information about diseases. This heightened awareness is likely to lead to increased utilization of nuclear medicine procedures, thereby driving market growth. As more healthcare providers recognize the value of these techniques, the industry is expected to expand significantly, aligning with the overall trends in personalized medicine.
Growing Investments in Healthcare Infrastructure
The Global Nuclear Medicine Market Industry benefits from growing investments in healthcare infrastructure, particularly in developing regions. Governments and private entities are increasingly allocating resources to enhance medical facilities and expand access to advanced diagnostic and therapeutic services. This trend is evident in countries such as India and Brazil, where initiatives to improve healthcare delivery systems are underway. As a result, the demand for nuclear medicine services is likely to rise, contributing to the market's projected growth to 10 USD Billion by 2035. Enhanced infrastructure facilitates the adoption of nuclear medicine technologies, ultimately improving patient care.
Technological Advancements in Radiopharmaceuticals
Technological advancements in radiopharmaceuticals significantly influence the Global Nuclear Medicine Market Industry. Innovations in drug development and imaging technologies enhance the efficacy and safety of nuclear medicine applications. For instance, the introduction of targeted radiotherapy agents has improved treatment outcomes for cancer patients. Moreover, advancements in imaging techniques, such as PET and SPECT, allow for more accurate disease detection and monitoring. As a result, the market is expected to grow at a compound annual growth rate of 4.43% from 2025 to 2035, reflecting the increasing reliance on these technologies in clinical settings.
Market Segment Insights
Nuclear Medicine Market Application Insights
<p>The Nuclear Medicine Market is experiencing significant growth, particularly within the Application segment. Within this segment, Diagnostic Imaging stands out with a valuation of 2.84 USD Billion in 2024, rising to 4.5 USD Billion by 2035, indicating its major role in providing critical imaging technologies that enhance patient diagnosis and treatment planning. This area is pivotal as it enables physicians to visualize the internal functions of organs and tissues in real-time, leading to timely and accurate medical interventions. </p>
<p>Following this, Therapeutic Applications are valued at 1.8 USD Billion in 2024 and expected to grow to 2.8 USD Billion by 2035. This segment plays a crucial role in treating diseases, such as cancer, using targeted radiotherapy that can minimize damage to surrounding healthy tissues, thus proving to be effective and beneficial for patient outcomes.</p>
<p>Additionally, Radiopharmaceutical Production is a vital component of the market, with a valuation of 1.2 USD Billion in 2024, expected to increase to 1.9 USD Billion by 2035. It is essential as it supports the development and supply of radioactive substances for diagnostic and therapeutic purposes, ensuring that medical facilities have access to the necessary materials to perform various nuclear medicine procedures. </p>
Nuclear Medicine Market Radioisotope Type Insights
<p>The Nuclear Medicine Market is projected to reach a valuation of 6.21 USD Billion by 2024, driven by various factors, including advancements in diagnostic techniques and increasing prevalence of chronic diseases. Among the Radioisotope Type segment, Technetium-99m stands out for its extensive use in diagnostic imaging, making it a key player in the market. </p>
<p>Iodine-131 is notably significant for its role in treating thyroid disorders, which further emphasizes its importance within the Nuclear Medicine Market. Fluorine-18, mainly utilized in positron emission tomography (PET) scans, continues to gain traction due to the growing demand for cancer diagnostics.Meanwhile, Yttrium-90 is recognized for its application in targeted beta therapy, enhancing treatment efficacy. The interplay of these radioisotopes underlines a strong market segmentation that reflects both diverse applications and growing trends in the Nuclear Medicine Market.</p>
<p>The rising geriatric population and expansion in research and development efforts significantly contribute to this market growth, as does the increasing awareness and accessibility of nuclear medicine technologies across the globe.</p>
Nuclear Medicine Market End User Insights
<p>The Nuclear Medicine Market, valued at 6.21 USD Billion in 2024, is witnessing diverse dynamics across its End User segment, which encompasses Hospitals, Diagnostic Imaging Centers, Academic Research Institutions, and Pharmaceutical Companies. Hospitals stand out as a crucial component, driving significant demand for nuclear medicine procedures primarily focused on diagnostics and therapeutic applications. Diagnostic Imaging Centers are also vital, facilitating advancements in imaging technologies that enhance the accuracy of disease diagnosis.Academic Research Institutions play a key role in the exploration and development of new radioisotopes and imaging techniques, greatly contributing to the overall market growth.</p>
<p>Furthermore, Pharmaceutical Companies are essential as they develop radiopharmaceuticals and invest in Research and Development to innovate treatment solutions.</p>
<p>With a compound annual growth rate projected at 4.43 from 2025 to 2035, the Nuclear Medicine Market segmentation indicates a robust evolution in this field driven by technological advancements, increasing patient populations, and a rise in chronic diseases globally.Market challenges include regulatory hurdles and the high cost of radioisotope production; however, opportunities for growth persist as demand for personalized medicine rises and advancements in nuclear technologies continue.</p>
Nuclear Medicine Market Procedure Insights
<p>The Nuclear Medicine Market, focusing on the Procedure segment, is projected to be valued at 6.21 USD Billion in 2024, reflecting a strong demand for advanced diagnostic and therapeutic procedures. This segment encompasses various techniques, including Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT), which play a crucial role in the early detection of diseases, particularly cancer. </p>
<p>PET, known for its high sensitivity, is becoming increasingly important in oncological imaging, while SPECT continues to be widely used due to its cost-effectiveness and accessibility.Additionally, Radiotherapy and Brachytherapy contribute significantly to the treatment landscape, offering targeted cancer therapies that enhance patient outcomes. The growth in this market is driven by an increasing prevalence of cancer, advancements in imaging technology, and growing investments in Research and Development. However, challenges such as high costs and regulatory hurdles may impact market expansion. </p>
<p>Nevertheless, the ongoing innovations and integrative approaches within these procedures present substantial opportunities for growth in the Nuclear Medicine Market, contributing to its significant evolution over the next decade.</p>
Get more detailed insights about Nuclear Medicine Market Research Report- Forecast till 2035
Regional Insights
The Nuclear Medicine Market is experiencing substantial growth across various regions, reflecting the increasing adoption of nuclear medicine in diagnostics and treatment. In 2024, North America leads the market with a valuation of 2.5 USD Billion, expected to reach 4.0 USD Billion in 2035, highlighting its majority holding in the sector due to advanced healthcare infrastructure and significant Research and Development investments.
Europe follows with a valuation of 1.8 USD Billion in 2024, projected to grow to 2.8 USD Billion by 2035, driven by strong regulations and a preference for non-invasive procedures.The Asia Pacific region, valued at 1.1 USD Billion in 2024 and growing to 1.8 USD Billion by 2035, is gaining traction thanks to increasing healthcare accessibility and patient awareness. In South America, the market is smaller, holding 0.4 USD Billion in 2024 and reaching 0.6 USD Billion by 2035, but showcases potential growth due to rising investments in healthcare.
The Middle East and Africa, valued at 0.41 USD Billion in 2024 and 0.8 USD Billion in 2035, represents a developing market with growing demand for diagnostic imaging. Each region's engagement highlights the varying degrees of market development and opportunity within the Nuclear Medicine Market segmentation.
Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review
Key Players and Competitive Insights
The Nuclear Medicine Market is characterized by its dynamic and competitive landscape, which plays a crucial role in the effective diagnosis and treatment of various diseases, particularly in oncology, cardiology, and neurology. As the demand for advanced imaging techniques increases, several key players are vying for a significant share of the market. These companies are continually investing in research and development to innovate and maintain strong product portfolios while also engaging in strategic partnerships and collaborations with healthcare providers and research institutions.
Such actions enable these firms to stay ahead in this highly specialized field, providing state-of-the-art solutions that enhance diagnostic accuracy and improve patient outcomes. The competitive environment is marked not only by technological advancements but also by regulatory challenges, reimbursement issues, and the need for extensive clinical validation. This further amplifies the rivalry among companies striving to offer safe, efficient, and effective nuclear medicine products.In the Nuclear Medicine Market, Bracco Imaging has established a solid presence owing to its innovative approaches and comprehensive product offerings.
The company focuses on the development of advanced radiopharmaceuticals and imaging agents that enhance the diagnostic process. With a robust portfolio that includes key imaging agents, Bracco Imaging effectively addresses the needs of healthcare professionals by providing high-quality products that equip them for accurate diagnostics in nuclear medicine.
The company's strengths lie in its commitment to research and development, which has enabled it to consistently launch new and improved products that meet regulatory requirements and address clinical expectations. Furthermore, Bracco Imaging's collaborations with healthcare institutions and strong distribution networks globally enhance its market reach and have a significant impact on its growth trajectory in the nuclear medicine sector.Bayer AG is a formidable player in the Nuclear Medicine Market, renowned for its innovative product offerings and solid market position.
The company has developed a range of radiopharmaceuticals and imaging agents that cater specifically to the realm of oncology and other serious medical conditions. Bayer AG’s strengths include its extensive research capabilities, which have led to the launch of several key products that are well-received in the market.
The company places significant emphasis on strategic mergers and acquisitions to bolster its product pipeline and expand its market presence. These strategic initiatives not only broaden its product offerings but also enhance its competitive edge in the global arena. Bayer AG is committed to advancing the field of nuclear medicine through ongoing investment in research and engaging in collaborations that explore novel therapies and diagnostic techniques, ensuring its position as a leader in the nuclear medicine landscape.
Key Companies in the Nuclear Medicine Market market include
Industry Developments
The Nuclear Medicine Market has seen notable developments recently, particularly with advancements in technology and increasing applications in clinical settings. Major players such as GE Healthcare and Siemens Healthineers are focusing on enhancing imaging techniques, which is vital for precise diagnostics.
In terms of recent mergers and acquisitions, Bracco Imaging announced the acquisition of a leading radiopharmaceutical company in August 2023, augmenting their product portfolio significantly. Additionally, Bayer AG completed the purchase of a niche radiopharmaceutical business in July 2023, further consolidating their presence in the market.
The impact of these activities is reflected in the market valuation, which is projected to grow due to technological advancements and increasing demand for targeted cancer therapies. Companies like Lantheus Medical Imaging are also expanding their offerings, which is expected to contribute to market growth in the upcoming years.
Other noteworthy developments in the last couple of years include the increased adoption of PET scans and the rise of personalized medicine, with advancements around March 2022 showcasing these trends gaining momentum globally. The Nuclear Medicine Market is poised for ongoing evolution as stakeholders invest in Research and Development to meet rising healthcare demands.
Future Outlook
Nuclear Medicine Market Future Outlook
<p>The Global Nuclear Medicine Market is projected to grow at a 11.35% CAGR from 2025 to 2035, driven by technological advancements, increasing cancer prevalence, and enhanced diagnostic capabilities.</p>
New opportunities lie in:
- <p>Develop targeted radiopharmaceuticals for personalized medicine applications. Invest in advanced imaging technologies to improve diagnostic accuracy. Expand global distribution networks to enhance market reach and accessibility.</p>
<p>By 2035, the Nuclear Medicine Market is expected to exhibit robust growth, reflecting advancements and increased adoption across healthcare sectors.</p>
Market Segmentation
Nuclear Medicine Market End User Outlook
- Hospitals
- Diagnostic Imaging Centers
- Academic Research Institutions
- Pharmaceutical Companies
Nuclear Medicine Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
Nuclear Medicine Market Procedure Outlook
- Positron Emission Tomography
- Single-Photon Emission Computed Tomography
- Radiotherapy
- Brachytherapy
Nuclear Medicine Market Application Outlook
- Diagnostic Imaging
- Therapeutic Applications
- Radiopharmaceutical Production
- Research Applications
Nuclear Medicine Market Radioisotope Type Outlook
- Technetium-99m
- Iodine-131
- Fluorine-18
- Yttrium-90
Report Scope
| Report Attribute/Metric | Details |
| Market Size 2024 | 10.63(USD Billion) |
| Market Size 2035 | 34.69 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 11.35% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Bracco Imaging, Bayer AG, Radiopharma, Nordion, GE Healthcare, Siemens Healthineers, Lantheus Medical Imaging, IHF Healthcare, Phillips Healthcare, NorthStar Medical Radioisotopes, Cardinal Health, Advanced Accelerator Applications, Elekta AB, Toshiba Medical Systems |
| Segments Covered | Application, Radioisotope Type, End User, Procedure, Regional |
| Key Market Opportunities | Increased demand for targeted therapies, Advancements in imaging technologies, Rising prevalence of chronic diseases, Growing investment in research and development, Expanding applications in personalized medicine |
| Key Market Dynamics | Innovative radiopharmaceuticals development, Increasing cancer prevalence, Growing aging population, Advancements in imaging technology, Supportive government initiatives |
| Countries Covered | North America, Europe, APAC, South America, MEA |
| Market Size 2025 | 11.84 (USD Billion) |
Market Highlights
Author
Latest Comments
John Doe
john@example.com
This is a great article! Really helped me understand the topic better.
Posted on July 23, 2025, 10:15
AM
Jane Smith
jane@domain.com
Thanks for sharing this. I’ve bookmarked it for later reference.
Posted on July 22, 2025, 7:45
PM
FAQs
What is the projected growth of the Nuclear Medicine market?
The Nuclear Medicine market is the expected increase in total market value of 34.69 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.
What is the size of the Nuclear Medicine market?
Nuclear Medicine market size was valued at approximately 10.63 billion USD in 2024. This figure will reach 34.69 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.
What is the CAGR of the Nuclear Medicine market?
Nuclear Medicine market is expected to grow at a CAGR of 11.35% between 2025 and 2035.
How much will the Nuclear Medicine market be worth by 2035?
Nuclear Medicine market is expected to be worth of 34.69 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.
How will the Nuclear Medicine market perform over the next 10 years?
Over the next 10 years the Nuclear Medicine market is expected to shift from usd billion 10.63 to 34.69 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.
Which region is expected to dominate the Nuclear Medicine Market by 2035?
North America is expected to dominate the market with a valuation of 4.0 USD Billion by 2035.
What are the market values for Diagnostic Imaging and Therapeutic Applications in 2024?
In 2024, the market value for Diagnostic Imaging is 2.84 USD Billion and for Therapeutic Applications is 1.8 USD Billion.
Who are the major players in the Nuclear Medicine Market?
Major players include Bracco Imaging, Bayer AG, GE Healthcare, and Cardinal Health, among others.
How does the Nuclear Medicine Market size differ between 2024 and 2035?
The market is expected to grow from 6.21 USD Billion in 2024 to 10.0 USD Billion in 2035.
What is the market value of Research Applications in the Nuclear Medicine Market by 2035?
The market value for Research Applications is projected to be 0.8 USD Billion by 2035.
-
Table of Contents
-
EXECUTIVE SUMMARY
-
Market Overview
-
Key Findings
-
Market Segmentation
-
Competitive Landscape
-
Challenges and Opportunities
-
Future Outlook
-
MARKET INTRODUCTION
-
Definition
-
Scope of the study
-
Research Objective
-
Assumption
-
Limitations
-
RESEARCH METHODOLOGY
-
Overview
-
Data Mining
-
Secondary Research
-
Primary Research
-
Primary Interviews and Information Gathering Process
-
Breakdown of Primary Respondents
-
Forecasting Model
-
Market Size Estimation
-
Bottom-Up Approach
-
Top-Down Approach
-
Data Triangulation
-
Validation
-
MARKET DYNAMICS
-
Overview
-
Drivers
-
Restraints
-
Opportunities
-
MARKET FACTOR ANALYSIS
-
Value chain Analysis
-
Porter's Five Forces Analysis
-
Bargaining Power of Suppliers
-
Bargaining Power of Buyers
-
Threat of New Entrants
-
Threat of Substitutes
-
Intensity of Rivalry
-
COVID-19 Impact Analysis
-
Market Impact Analysis
-
Regional Impact
-
Opportunity and Threat Analysis
-
Nuclear Medicine Market, BY Application (USD Billion)
-
Diagnostic Imaging
-
Therapeutic Applications
-
Radiopharmaceutical Production
-
Research Applications
-
Nuclear Medicine Market, BY Radioisotope Type (USD Billion)
-
Technetium-99m
-
Iodine-131
-
Fluorine-18
-
Yttrium-90
-
Nuclear Medicine Market, BY End User (USD Billion)
-
Hospitals
-
Diagnostic Imaging Centers
-
Academic Research Institutions
-
Pharmaceutical Companies
-
Nuclear Medicine Market, BY Procedure (USD Billion)
-
Positron Emission Tomography
-
Single-Photon Emission Computed Tomography
-
Radiotherapy
-
Brachytherapy
-
Nuclear Medicine Market, BY Regional (USD Billion)
-
North America
-
US
-
Canada
-
Europe
-
Germany
-
UK
-
France
-
Russia
-
Italy
-
Spain
-
Rest of Europe
-
APAC
-
China
-
India
-
Japan
-
South Korea
-
Malaysia
-
Thailand
-
Indonesia
-
Rest of APAC
-
South America
-
Brazil
-
Mexico
-
Argentina
-
Rest of South America
-
MEA
-
GCC Countries
-
South Africa
-
Rest of MEA
-
Competitive Landscape
-
Overview
-
Competitive Analysis
-
Market share Analysis
-
Major Growth Strategy in the Nuclear Medicine Market
-
Competitive Benchmarking
-
Leading Players in Terms of Number of Developments in the Nuclear Medicine Market
-
Key developments and growth strategies
-
New Product Launch/Service Deployment
-
Merger & Acquisitions
-
Joint Ventures
-
Major Players Financial Matrix
-
Sales and Operating Income
-
Major Players R&D Expenditure. 2023
-
Company Profiles
-
MediRadiant
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Bracco Imaging
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Nordion
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
TheraBiologics
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
United Imaging Healthcare
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Philips
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Canon Medical Systems
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
SelenoMed
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Radiopharm Theranostics
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
AquaBounty Technologies
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Lantheus Medical Imaging
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Bayer
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Elekta
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Siemens
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
General Electric
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Appendix
-
References
-
Related Reports
Nuclear Medicine Market Segmentation
Nuclear Medicine Market By Application (USD Billion, 2019-2035)
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
Nuclear Medicine Market By Radioisotope Type (USD Billion, 2019-2035)
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
Nuclear Medicine Market By End User (USD Billion, 2019-2035)
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
Nuclear Medicine Market By Procedure (USD Billion, 2019-2035)
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
Nuclear Medicine Market By Regional (USD Billion, 2019-2035)
North America
Europe
South America
Asia Pacific
Middle East and Africa
Nuclear Medicine Market Regional Outlook (USD Billion, 2019-2035)
North America Outlook (USD Billion, 2019-2035)
North America Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
North America Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
North America Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
North America Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
North America Nuclear Medicine Market by Regional Type
US
Canada
US Outlook (USD Billion, 2019-2035)
US Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
US Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
US Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
US Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
CANADA Outlook (USD Billion, 2019-2035)
CANADA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
CANADA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
CANADA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
CANADA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
Europe Outlook (USD Billion, 2019-2035)
Europe Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
Europe Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
Europe Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
Europe Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
Europe Nuclear Medicine Market by Regional Type
Germany
UK
France
Russia
Italy
Spain
Rest of Europe
GERMANY Outlook (USD Billion, 2019-2035)
GERMANY Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
GERMANY Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
GERMANY Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
GERMANY Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
UK Outlook (USD Billion, 2019-2035)
UK Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
UK Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
UK Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
UK Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
FRANCE Outlook (USD Billion, 2019-2035)
FRANCE Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
FRANCE Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
FRANCE Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
FRANCE Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
RUSSIA Outlook (USD Billion, 2019-2035)
RUSSIA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
RUSSIA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
RUSSIA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
RUSSIA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
ITALY Outlook (USD Billion, 2019-2035)
ITALY Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
ITALY Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
ITALY Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
ITALY Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
SPAIN Outlook (USD Billion, 2019-2035)
SPAIN Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
SPAIN Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
SPAIN Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
SPAIN Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
REST OF EUROPE Outlook (USD Billion, 2019-2035)
REST OF EUROPE Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
REST OF EUROPE Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
REST OF EUROPE Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
REST OF EUROPE Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
APAC Outlook (USD Billion, 2019-2035)
APAC Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
APAC Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
APAC Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
APAC Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
APAC Nuclear Medicine Market by Regional Type
China
India
Japan
South Korea
Malaysia
Thailand
Indonesia
Rest of APAC
CHINA Outlook (USD Billion, 2019-2035)
CHINA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
CHINA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
CHINA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
CHINA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
INDIA Outlook (USD Billion, 2019-2035)
INDIA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
INDIA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
INDIA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
INDIA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
JAPAN Outlook (USD Billion, 2019-2035)
JAPAN Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
JAPAN Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
JAPAN Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
JAPAN Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
SOUTH KOREA Outlook (USD Billion, 2019-2035)
SOUTH KOREA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
SOUTH KOREA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
SOUTH KOREA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
SOUTH KOREA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
MALAYSIA Outlook (USD Billion, 2019-2035)
MALAYSIA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
MALAYSIA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
MALAYSIA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
MALAYSIA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
THAILAND Outlook (USD Billion, 2019-2035)
THAILAND Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
THAILAND Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
THAILAND Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
THAILAND Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
INDONESIA Outlook (USD Billion, 2019-2035)
INDONESIA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
INDONESIA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
INDONESIA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
INDONESIA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
REST OF APAC Outlook (USD Billion, 2019-2035)
REST OF APAC Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
REST OF APAC Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
REST OF APAC Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
REST OF APAC Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
South America Outlook (USD Billion, 2019-2035)
South America Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
South America Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
South America Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
South America Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
South America Nuclear Medicine Market by Regional Type
Brazil
Mexico
Argentina
Rest of South America
BRAZIL Outlook (USD Billion, 2019-2035)
BRAZIL Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
BRAZIL Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
BRAZIL Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
BRAZIL Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
MEXICO Outlook (USD Billion, 2019-2035)
MEXICO Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
MEXICO Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
MEXICO Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
MEXICO Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
ARGENTINA Outlook (USD Billion, 2019-2035)
ARGENTINA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
ARGENTINA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
ARGENTINA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
ARGENTINA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
REST OF SOUTH AMERICA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
REST OF SOUTH AMERICA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
REST OF SOUTH AMERICA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
REST OF SOUTH AMERICA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
MEA Outlook (USD Billion, 2019-2035)
MEA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
MEA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
MEA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
MEA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
MEA Nuclear Medicine Market by Regional Type
GCC Countries
South Africa
Rest of MEA
GCC COUNTRIES Outlook (USD Billion, 2019-2035)
GCC COUNTRIES Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
GCC COUNTRIES Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
GCC COUNTRIES Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
GCC COUNTRIES Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
SOUTH AFRICA Outlook (USD Billion, 2019-2035)
SOUTH AFRICA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
SOUTH AFRICA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
SOUTH AFRICA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
SOUTH AFRICA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
REST OF MEA Outlook (USD Billion, 2019-2035)
REST OF MEA Nuclear Medicine Market by Application Type
Diagnostic Imaging
Therapeutic Applications
Radiopharmaceutical Production
Research Applications
REST OF MEA Nuclear Medicine Market by Radioisotope Type
Technetium-99m
Iodine-131
Fluorine-18
Yttrium-90
REST OF MEA Nuclear Medicine Market by End User Type
Hospitals
Diagnostic Imaging Centers
Academic Research Institutions
Pharmaceutical Companies
REST OF MEA Nuclear Medicine Market by Procedure Type
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Radiotherapy
Brachytherapy
Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment